1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing number of patients with diabetes
4.1.2. Restraints
4.1.2.1. Adverse effects associated with diabetes devices
4.1.3. Opportunity
4.1.3.1. Advancement in novel devices
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Analysis
9. By Product
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.1.2. Market Attractiveness Index, By Product
9.2. Blood Glucose Meter Devices*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.2.3. Self-Monitoring Devices
9.2.3.1. Blood Glucose Meters
9.2.3.2. Testing Strips
9.2.3.3. Lancets
9.2.4. Continuous Glucose Monitoring Devices
9.2.4.1. Sensors
9.2.4.2. Transmitters
9.2.4.3. Receiver
9.3. Insulin Delivery Devices
9.3.1.1. Pumps
9.3.1.2. Pens
9.3.1.3. Syringes
9.3.1.4. Jet Injectors
10. By End-user
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.1.2. Market Attractiveness Index, By End-user
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Homecare
10.4. Diagnostic Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.5.1. The U.S.
11.2.5.2. Canada
11.2.5.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.5.1. Germany
11.3.5.2. The U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.5.1. Brazil
11.4.5.2. Argentina
11.4.5.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.5.1. China
11.5.5.2. India
11.5.5.3. Japan
11.5.5.4. Australia
11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Product Benchmarking
12.3. Company Share Analysis
12.4. Key Developments and Strategies
13. Company Profiles
13.1. Medtronic plc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Abbott Laboratories
13.3. F.Hoffmann-La-Ltd.
13.4. Bayer AG
13.5. Lifescan, Inc.
13.6. B Braun Melsungen AG
13.7. Novo Nordisk
13.8. Dexcom Inc.
13.9. Insulet Corporation
13.10. Ypsomed Holdings
14. Appendix
14.1. About Us and Services
14.2. Contact Us